However, it has been observed that abnormally high levels of PD-L1 expression on certain tumor cells, including those in breast and lung cancers, can lead to the downregulation of immune cells, aiding tumor cells in evading the immune system (143, 144). The gene discussed is CD274; the disease is neoplasm.